feed,title,long_url,short_url
Benzinga,EPRI CEO Tells NARUC: Hydrogen's Moment Has Arrived,https://www.benzinga.com/pressreleases/21/02/n19701425/epri-ceo-tells-naruc-hydrogens-moment-has-arrived,https://j.mp/3aqDD24
Benzinga,AARP Community Challenge Grant Program Now Accepting 2021 Applications,https://www.benzinga.com/pressreleases/21/02/n19701424/aarp-community-challenge-grant-program-now-accepting-2021-applications,https://j.mp/2ZraUUO
Benzinga,Pulse8's Qualit8 Solution receives NCQA Measure Certification Program™ for HEDIS® MY 2020 Season,https://www.benzinga.com/pressreleases/21/02/b19701422/pulse8s-qualit8-solution-receives-ncqa-measure-certification-program-for-hedis-my-2020-season,https://j.mp/3pBQ6oh
Benzinga,Canada Games Launches New Brand Poised to Spark Greatness in the Next Generation,https://www.benzinga.com/pressreleases/21/02/n19701406/canada-games-launches-new-brand-poised-to-spark-greatness-in-the-next-generation,https://j.mp/3pqE00V
Benzinga,X-Terra Resources Drills Longest Gold Intercept on Grog Project to Date,https://www.benzinga.com/pressreleases/21/02/n19701405/x-terra-resources-drills-longest-gold-intercept-on-grog-project-to-date,https://j.mp/3qvCVGm
Benzinga,PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19,https://www.benzinga.com/pressreleases/21/02/n19701404/ptc-therapeutics-reports-the-initiation-of-the-second-stage-of-the-fite19-phase-23-clinical-trial-,https://j.mp/3s2T4Ud
Benzinga,Qorus Joins with Highspot to Enable Personalized and Efficient Proposal Responses,https://www.benzinga.com/pressreleases/21/02/n19701403/qorus-joins-with-highspot-to-enable-personalized-and-efficient-proposal-responses,https://j.mp/2M2EbSC
Benzinga,Qorus Joins with Highspot to Enable Personalized and Efficient Proposal Responses,https://www.benzinga.com/pressreleases/21/02/n19701402/qorus-joins-with-highspot-to-enable-personalized-and-efficient-proposal-responses,https://j.mp/3s6lUDl
Benzinga,Novelis Debuts New Aluminum Solution Category for Automakers,https://www.benzinga.com/pressreleases/21/02/n19701401/novelis-debuts-new-aluminum-solution-category-for-automakers,https://j.mp/37p8la9
Benzinga,"U.S. Neurovascular Devices Market to Reach $1.07 Bn, by 2027 at 3.8% CAGR: Allied Market Research",https://www.benzinga.com/pressreleases/21/02/n19701399/u-s-neurovascular-devices-market-to-reach-1-07-bn-by-2027-at-3-8-cagr-allied-market-research,https://j.mp/3rWtjVq
Benzinga,Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Recurrent GBM,https://www.benzinga.com/pressreleases/21/02/n19701398/kintara-therapeutics-enrolls-final-patient-in-phase-2-clinical-trial-of-val-083-for-recurrent-gbm,https://j.mp/3ptncGG
Benzinga,"Syniti Completes Record Growth Year, Prepares for Continued Momentum in 2021",https://www.benzinga.com/pressreleases/21/02/n19701397/syniti-completes-record-growth-year-prepares-for-continued-momentum-in-2021,https://j.mp/3dlwNNt
Benzinga,Amyris To Host Fourth Quarter And Full Year 2020 Financial Results Conference Call On March 2,https://www.benzinga.com/pressreleases/21/02/n19701396/amyris-to-host-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-march-2,https://j.mp/2ZqEtpu
Benzinga,Hoth Therapeutics to Present at the Diamond Equity Research Emerging Growth Invitational 2021 Virtual Conference,https://www.benzinga.com/pressreleases/21/02/n19701395/hoth-therapeutics-to-present-at-the-diamond-equity-research-emerging-growth-invitational-2021-virt,https://j.mp/2OGYgP7
Benzinga,"Half of Homes In Seattle and Washington, D.C. Are In Economically Integrated Neighborhoods--a Bigger Share Than Other Major U.S. Cities",https://www.benzinga.com/pressreleases/21/02/n19701394/half-of-homes-in-seattle-and-washington-d-c-are-in-economically-integrated-neighborhoods-a-bigger-,https://j.mp/2ZrYr2W
